Skip to main content
RGNX
NASDAQ Life Sciences

REGENXBIO Posts $0.62 Per-Share Q3 Loss as FDA Hold Weighs on Gene Therapy Pipeline

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$8.003
Mkt Cap
$508.962M
52W Low
$5.455
52W High
$16.19
52W Position info
47% above low
Off High info
51% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

RGNX sits 47% above its 52-week low of $5.455.

Summary

REGENXBIO reported a third-quarter loss of $40.7 million, or $0.62 per share, per Dow Jones, on revenue of $9.2 million. That follows a rough stretch: the FDA placed a clinical hold on the Hunter syndrome gene therapy RGX-121 in late August, and management said it does not expect to resubmit the BLA in the near term. The company did bank $39.0 million in cash in September by settling all ELEVIDYS patent litigation with Sarepta, which helps offset the cash burn. With a small market cap and a going-concern-flagged ATM already in place, the size of this quarterly loss relative to the balance sheet is the number that matters. Watch for the full 10-Q and any update on cash runway, which now extends into late Q4 2027.

At the time of this announcement, RGNX was trading at $8.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $509M. The 52-week trading range was $5.46 to $16.19. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

RGNX - Latest Insights

RGNX
Nov 05, 2026, 7:20 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.00
Real-time Price: $7.12 info
Change: -$0.880 (-11%) info
Market Cap: $473.438M info
RGNX
Sep 23, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.61
Real-time Price: $7.12 info
Change: -$0.490 (-6%) info
Market Cap: $473.438M info
RGNX
Aug 24, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.07
Real-time Price: $7.12 info
Change: -$0.950 (-12%) info
Market Cap: $473.438M info
RGNX
Aug 24, 2026, 8:39 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $8.47
Real-time Price: $7.12 info
Change: -$1.35 (-16%) info
Market Cap: $473.438M info
RGNX
Aug 06, 2026, 7:39 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $10.99
Real-time Price: $7.12 info
Change: -$3.87 (-35%) info
Market Cap: $473.438M info